EP 2729174 A1 20140514 - IL-23 ANTAGONISTS FOR TREATMENT OR PREVENTION OF SKIN RASH ASSOCIATED WITH TREATMENT WITH P13K/AKT PATHWAY INHIBITORS
Title (en)
IL-23 ANTAGONISTS FOR TREATMENT OR PREVENTION OF SKIN RASH ASSOCIATED WITH TREATMENT WITH P13K/AKT PATHWAY INHIBITORS
Title (de)
IL-23-ANTAGONISTEN ZUR BEHANDLUNG ODER VORBEUGUNG VON HAUTAUSSCHLAG IM ZUSAMMENHANG MIT EINER BEHANDLUNG MIT P13K/AKT-SIGNALWEGINHIBITOREN
Title (fr)
ANTAGONISTES DE L'IL-23 UTILISABLES EN VUE DU TRAITEMENT OU DE LA PRÉVENTION D'ÉRUPTIONS CUTANÉES ASSOCIÉES À UN TRAITEMENT PAR DES INHIBITEURS DE LA VOIE PI3K/AKT
Publication
Application
Priority
- US 201161505946 P 20110708
- US 201161547549 P 20111014
- US 2012045363 W 20120703
Abstract (en)
[origin: WO2013009535A1] The present invention provides methods for use of interleukin-23 (IL-23) antagonists to treat or prevent skin rash associated with treatment with PI3K/AKT pathway inhibitors, such as treatment of cancer.
IPC 8 full level
A61K 39/395 (2006.01)
CPC (source: EP)
A61K 39/3955 (2013.01); A61K 45/06 (2013.01); C07K 16/244 (2013.01); A61K 2039/505 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01)
C-Set (source: EP)
Citation (search report)
See references of WO 2013009535A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
DOCDB simple family (application)
US 2012045363 W 20120703; EP 12811568 A 20120703